Zanubrutinib for treating relapsed or refractory mantle cell lymphoma

Evaluation committee members

The 4 technology appraisal committees are standing advisory committees of NICE. This topic was considered as a streamlined evaluation by the lead team of committee C.

Committee members are asked to declare any interests in the technology being evaluated. If it is considered there is a conflict of interest, the member is excluded from participating further in that evaluation.

Chair

Steve O'Brien
Chair, technology appraisal committee C

NICE project team

Each evaluation is assigned to a team consisting of 1 or more health technology analysts (who act as technical leads for the evaluation), a technical adviser, a project manager and an associate director.

Emma Bajela
Technical lead

Alan Moore
Technical adviser

Leena Issa
Project manager

Lorna Dunning
Associate director

ISBN: 978-1-4371-7103-9